In the Fall issue of OAC’s Weight Matters Magazine, we shine a light on some troubling gaps in the FDA drug approval process and drug labeling that are hurting people with obesity. Currently, there are no FDA requirements to evaluate how prescription drugs perform in individuals with obesity. If this comes as a surprise to
Read Article